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Succinate-Ubiquinone  Oxidoreductase, and Ubiquinol-Cytochrome c 
Oxidoreductase in  the Reduction of Exogenous Quinones* 
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Qin-shi Zhu and Diana S. Beattie$ 
From the  Department of Biochemistry,  West  Virginia  Uniuersity, School of Medicine, Morgantown, West  Virginia 26506 
The reduction of the following exogenous quinones 
by succinate  and NADH was studied  in mitochondria 
isolated from both wild type and ubiquinone (Q)-defi- 
cient strains of yeast: ubiquinone-0 (Q,,), ubiquinone-1 
(Q1), ubiquinone-2 (Q2), and its decyl analogue 2,3- 
dimethoxy-5-methyl-6-decyl-1,4-benzoquinone (DB), 
duroquinone (DQ), menadione (MQ), vitamin K1 (2- 
methyl-3-phytyl-1,4-naphthoquinone), the plastoqui- 
none analogue 2,3,6-trimethyl-1,4-benzoquinone 
(PQocl), plastoquinone-2 (PQ2), and its decyl analogue 
(2,3-dimethyl-6-decy1-1,4-benzoquinone). Reduction 
of the  small quinones DQ, 80, Ql, and PQo,l by NADH 
occurred  in both wild type  and Q-deficient mitochon- 
dria in a reaction  inhibited more than 50% by  myxo- 
thiazol and less than 20% by antimycin. The reduction 
of these small quinones by succinate also occurred in 
wild type mitochondria in a reaction  inhibited more 
than 50% by antimycin but did not occur in Q-deficient 
mitochondria suggesting that endogenous QB is in- 
volved in their reduction. In addition,  the  inhibitory 
effects of antimycin  and myxothiazol, specific inhibi- 
tors of the cytochrome b-cl complex,  on the reduction 
of these small quinones suggest the involvement of this 
complex in  the electron transfer reaction. By contrast, 
the reduction of  Qz and DB  by succinate  was  insensitive 
to  inhibitors  and by NADH was 20-30% inhibited by 
myxothiazol suggesting that these analogues are di- 
rectly reduced by the primary dehydrogenases. The 
dependence of the  sensitivity to the  inhibitors on the 
substrate used suggests that succinate-ubiquinone ox- 
idoreductase interacts specifically with  center i (the 
antimycin-sensitive  site)  and NADH ubiquinone oxi- 
doreductase  preferentially  with  center o (the myxo- 
thiazol-sensitive site) of the cytochrome b-el complex. 
The NADH dehydrogenase involved in  the myxothia- 
zol-sensitive quinone reduction faces  the  matrix  side 
of the  inner membrane suggesting that center o may 
be localized within  the membrane at a similar depth as 
center i. 
The mitochondrial respiratory chain is considered to be 
composed of discrete  lipid-protein  enzyme complexes, each of 
which catalyzes  a distinct  part of the overall oxidation reac- 
tion. Ubiquinone, by virtue of its  stoichiometric  abundance, 
its hydrophobicity, and small molecular weight, has been 
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considered to  act  as  mobile electron  carrier between NADH- 
ubiquinone (Q)’ oxidoreductase (complex I), succinate-Q ox- 
idoreductase  (complex 11), other  primary dehydrogenases and 
ubiquinol  (QH&cytochrome c oxidoreductase  (complex 111). 
In  support of this view, Kroger and Klingenberg (1) demon- 
strated  that 80-90% of the ubiquinone (Q) pool is homoge- 
neous such that each ubiquinone molecule rapidly reaches 
and  interacts  with  many dehydrogenase and cytochrome b-cl 
complex molecules. Recent  studies  in Hackenbrock’s  labora- 
tory (2, 3) have also provided convincing evidence that  the 
respiratory  chain complexes as well as ubiquinone are free to 
diffuse laterally  and  independently of each other in the  plane 
of the  mitochondrial  membrane. 
On  the  other  hand,  the id a that ubiquinone can be reduced 
through  direct  interaction between the  primary dehydrogen- 
ases  and  the cytochrome b-c, complex has also  been suggested. 
Such a direct interaction was implicated initially in the Q 
cycle in which succinate dehydrogenase was proposed to  do- 
nate an electron at center i to form ubiquinol (4). Several 
types of experimental evidence have provided evidence for the 
direct  interaction of the complexes. For example, the  sensitiv- 
ity  to  antimycin of duroquinone (DQ) reduction by succinate 
implies the possibility of a direct  interaction between succi- 
nate-Q oxidoreductase and  center i of the cytochrome b-c, 
complex (5 ,  6). Similarly, Ragan  and  Heron (7, 8) proposed 
that  electron  transfer  can occur in a complex 1-111 “supercom- 
plex”  based on  the  kinetics of electron  transfer from  isolated 
complex I to complex 111. Interestingly, pool kinetics  can  still 
be realized in  this  system if complex I and 111 can move freely 
around each other. From the dependence of the ubiquinol 
oxidation  capacity (V,) of the  respiratory  chain  on  the sub- 
strate used, Zhu et al. (9) concluded that  both  the free move- 
ment of ubiquinone molecules and  the  direct ollision between 
ubiquinone-reducing and ubiquinol-oxidizing enzymes may 
play  a  role in  electron  transfer  through  the Q pool. 
Further evidence  for the  direct  interaction of the  different 
complexes of the  respiratory  chain includes the isolation of 
1:III and 1I:III supercomplexes (10, 111, the  presence of the 
two small  subunits of succinate-ubiquinone oxidoreductase in 
the cytochrome b-cl complex after removal of succinate de- 
hydrogenase by alkali (12), and  the specific interaction be- 
tween complexes I1 and I11 (13). In an  earlier study (6), we 
The abbreviations and trivial names used are: Q(H2), ubiquinol 
(reduced ubiquinone); b-c, complex, mitochondrial ubiquinol-cyto- 
chrome c oxidoreductase; Qo, ubiquinone without a side chain; Ql,  Q2, 
QB, ubiquinone with side chains containing 1,2,  and 6 isoprene units, 
respectively; DB, 2,3-dimethoxy-5-methyl-6-decyl-1,4-benzoquinone; 
DQ, duroquinone, 2,3,5,6-tetramethyl-1,4-benzoquinone; MQ, mena- 
dione, l,-l-naphthoquinone, vitamin KO; vitamin K,, 2-methyl-3-phy- 
tyl-1,4-naphthoquinone; 2,3,6-trimethyl-1,4-benzoquinone; 
PQoClo, 2,3-dimethyl-6-decyl-l,4-benzoquinone; PQ2, plastoquinone- 
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TABLE I1 
Reduetion of erogenous quinones by succinate and the inhibition by antimycin and rnyxothiazol 
Mitochondria (concentration of cytochrome c, 0.016 pM) were  incubated with quinones in  the standard  buffer 
for 5 min in the presence of 1.6 mM KCN and the reaction started by addition of 2 mM succinate. Antimycin (2 
p ~ )  and myxothiazol (2 p ~ ) ,  when used, were  added to the standard  buffer immediately after the mitochondria. 
In calculating the specific activities, it was arbitrarily assumed that the extinction coefficient in buffer at all 
wavelength pairs is 8 mM” cm”. This value will give approximate, but nevertheless, close values to the specific 
activities and will not affect the percentage  of inhibition. The concentrations of the quinones were:  DQ, QO, Q2, 
DB, MQ, PQ~elo, and PQ2,40 pM; Q1, 22 pM; PQhl, 112 p ~ .  Stimulation of activity is expressed by  a negative sign. 
Inhibition ( W )  
Activity 
(nmol Q min” mg”) Quinone Wavelength pairs 
~~ 
Antimycin Myxothiazol 
Antimycin 
+ 
myxothiazol 
M” W M W M W M W 
nrn 
DQ 266-290 1.5 7.0 65 
Qo 268-290 1.2 10.8 55 
61 275-290 1.1 13.9 95 
6 2  275-290 16.4 18.8 0 0 
DB 279-290 18.0 15.6 -9  -23 
MQ 264-290 0 0 
Vitamin K, 264-290 0 0 
P Q ~ I  
PQom 260-280 1.7 16.5 
PQ2 260-280 0.9 14.8 
- 
- 
- 
- - 
- - 
260-280 1.3 21.9 - 71 
-36 
-72 
- 
- 
M and W  refer to mutant (Q-deficient) and wild type mitochondria. 
0 
-9 
0 
0 
-23 - - 
-6 
22 
-30 
- 75 
77 
87 
-1 0 
-10 14 
- 
- 
- - 
- - 
- 73 
93 
97 
- 
- 
proposed an interaction between complexes I1 and I11 based 
on  the antimycin-sensitivity of DQ and plastoquinone reduc- 
tion by succinate in submitochondrial particles and isolated 
succinate-cytochrome c reductase. 
The  current study provides further evidence for the direct 
interaction between the primary dehydrogenases and  the cy- 
tochrome b-cl complex in  the reduction of several quinones 
and quinone analogues in both wild type and ubiquinone- 
deficient yeast mitochondria. In addition, the inhibition of 
quinone reduction by antimycin with succinate as  substrate 
and by myxothiazol with NADH as substrate suggests that 
succinate-Q oxidoreductase specifically interacts with center 
i  and NADH-Q oxidoreductase preferentially with center o of 
the cytochrome b-cl complex. Since the NADH dehydrogen- 
ase involved in quinone reduction has been shown to face the 
matrix side of the  inner membrane, we also suggest that center 
o may actually be localized in  the center  rather than on the 
outer side of the membrane. 
MATERIALS AND  METHODS 
RESULTS~ 
Reduction of Exogenous Quinones by Succinate-The rates 
of reduction of various exogenous quinones by succinate ob- 
served in mitochondria isolated from both wild-type and Q- 
deficient yeast cells and  the sensitivity of the reactions to 
antimycin and myxothiazol are summarized in Table 11. 
The reduction by succinate of the “small” quinones: DQ, 
Qo,  Q1, and PQocl in wild type mitochondria was significantly 
inhibited by antimycin, but was essentially insensitive to 
myxothiazol. Similar results were previously reported with 
DQ as  substrate in pig heart mitochondria (6). The reduction 
of PQ&lo and  PQ2 by succinate in wild type mitochondria was 
also largely inhibited when both antimycin and myxothiazol 
were present,  but antimycin or myxothiazol alone had little 
Portions of this paper (including “Materials and Methods,” part 
of “Results,” Tables I and VI, and Fig. 1) are presented in miniprint 
at the end of this paper. Miniprint is easily read with the aid of a 
standard magnifying glass. Full size photocopies are  included in the 
microfilm edition of the Journal that  is available from  Waverly Press. 
or no effect. Previously, we had reported that  in pig heart 
mitochondria succinate could reduce PQ2 in an antimycin- 
sensitive reaction and PQoclo in  a reaction sensitive to  the 
combined effects of myxothiazol and antimycin (6). These 
results suggest that  the pathway of electron transfer from 
succinate to these small quinones must involve the cyto- 
chrome b-cl complex  where these inhibitors specifically act. 
A much slower rate of reduction of all these quinones by 
succinate was detected in Q-deficient mitochondria suggesting 
that endogenous ubiquinone is required for the reduction by 
succinate of all plastoquinone-type quinones and the ubiqui- 
none-type quinones without a side chain or with a side chain 
not longer than 5 carbons? 
By contrast, the reduction of DB and Q2 occurred at a 
similar rate in both wild type and Q-deficient mitochondria, 
and was not sensitive to antimycin or myxothiazol or  their 
combined use. Succinate dehydrogenase must thus directly 
reduce these compounds probably by the same pathway in- 
volved in the reduction of endogenous quinones. 
Menadione and vitamin K1, due to their low mid-point 
potentials, could not be  reduced by succinate by either mito- 
chondrial preparation. 
Reduction of Exogenous Quinones by NADH-When 
NADH  was  used as  the reductant  instead of succinate, major 
differences were  observed (Table 111). 1) The quinone reduc- 
tion rate was 10-20 times faster than that observed with 
succinate as electron acceptor. The observed faster rate of 
quinone reduction by NADH compared to succinate may 
reflect the presence of two  NADH dehydrogenases in yeast 
mitochondria. It should be noted, however, that  the  rate of 
NADH-DQ oxidoreductase in beef heart mitochondria was 
346 nmol of Q min” mg” (Fig. 2 ) ,  a value comparable to  that 
observed with yeast mitochondria. 2 )  The reduction of the 
small quinones: DQ,  Qo, Q1, and PQocl  was not or only slightly 
inhibited by antimycin, but was significantly inhibited by 
myxothiazol. The sensitivity to myxothiazol was greater with 
the Q-deficient (55-75%) than with the wild type mitochon- 
dria (40-50%).  3) The reduction of these quinones as well as 
PQo,lo and PQ2 no longer required endogenous Q6. When the 
Zhu,  Q. S., and Beattie, D. S., submitted for publication. 
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TABLE 111 
Reduction of exogenous quinones by NADH and the effect of antimycin and myxothiazol 
The experimental conditions and  the calculation of specific activities were the same as in Table I1 except that 
the cytochrome c1 concentration was 0.004 phi and 50 phi NADH replaced succinate. When the specific activities 
were calculated from NADH oxidation monitored at 340-380 nm, an extinction coefficient of 5 mM" cm" was 
used. 
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Inhibition (%) 
Activity 
Quinone Wavelength  ( mol Q min" mg") 
Antimycin 
myxothiazol pairs 
Antimycin  Myxothiazol + 
M" W M W M W M W 
DQ 340-380  270 169 0 
90 270-247  240 135 13 
91 270-247 301 171 14 
Qz 340-380 488 370 0 
DB 340-380 360 165 0 
MQb 340-380  290  262 12 
Vitamin K, 340-380 0 0 
PQ,, 340-380 300 173 0 
PQocm 340-380 87 137 -3 
PQz 340-380  340  355  -6 
M and W refer to mutant (Q-deficient) and wild type mitochondria. 
In the wild type the wavelength pair 270-247 nm  was  used. 
270-2C7 nm 
+anti. 
+ myxo. 
+myxo. 
- 
2Osec 
control 
FIG. 2. Reduction of DQ by NADH in beef heart mitochon- 
dria. The experimental conditions were the same as in Table 111, 
except that beef heart mitochondria (cytochrome c1 concentration, 
0.016 hi) replaced yeast mitochondria. 
small quinones were  used as electron acceptors, the reduction 
rate was faster in the mitochondria from the Q-deficient 
mutant  than  in those from the wild type cells suggesting that 
the presence of  Q6 was actually inhibitory to  the reduction of 
exogenous quinones. One explanation is that  the diffusion of 
endogenous Q from the dehydrogenase to  the b-cl complex is 
the rate-limiting step in this reaction. 4) Menadione was 
reduced at  the similar rate  as  the other small quinones and 
with the same pattern of inhibition. However, vitamin K,, a 
naphthoquinone with the same ring as menadione and a 
phytyl side chain similar in structure to  that of  Q3, could not 
be reduced by NADH either in the wild type or Q-deficient 
mitochondria. 5) The reduction of PQoClo and PQz was 40- 
50% inhibited by myxothiazol in wild type mitochondria but 
lacked such sensitivity to myxothiazol in  the Q mutant. It 
should be noted that  the reduction of  PQo,,o proceeded at a 
much slower rate than  that of PQ,. 6) The reduction of DB 
and Q2 in both wild and  Q  mutant mitochondria was inhibited 
8 69 
19 62 
17 82 
0 15 
19 20 
8 75 
10 53 
0 0 
0 0 
43  69 
40 63 
78 42 
21 10 
32 12 
38 76 
34 53 
37 0 
50 -6 
63 
40 
100 
30 
36 
54 
52 
40 
51 
20-30% by myxothiazol. It should be recalled that  the reduc- 
tion of these quinones by succinate was not inhibited by either 
antimycin or myxothiazol. These results indicate that the 
reduction of various analogues of ubiquinone by NADH also 
involves electron transfer through the cytochrome b-cl com- 
plex and that  the sensitivity to antimycin and myxothiazol 
depends on the substrate used. We suggest that these results 
can be explained by direct protein-protein interactions be- 
tween the primary dehydrogenases and the cytochrome b-c, 
complex. 
The Sideness of the NADH Dehydrogenase Which Is Re- 
sponsible for the Myxothiuzol  Sensitivity-In yeast, there is a 
single succinate-Q reductase located on the matrix side of the 
mitochondrial inner membrane. Two different kinds of 
NADH-Q reductase, however, are  present in yeast mitochon- 
dria. One reductase is located at  the matrix side while the 
other is located on the cytoplasmic side of the membrane; 
however, both reductases interact with the b-c, complex 
through the Q pool (21). Identification of the NADH-Q re- 
ductase which is responsible for the myxothiazol-sensitive 
reduction of small quinones may suggest a location in the 
membrane for center 0, where myxothiazol has been shown 
to  act (22). In the experiments described previously in this 
paper, mitochondria were obtained by breaking yeast cells 
with glass beads, and hence may have become fragmented. 
Indeed, significant succinate-Q reductase activity was ob- 
served after addition of the impermeable substrate, succinate. 
Therefore NADH added externally to such mitochondrial 
preparations would  be accessible by both NADH-Q reductase 
complexes. To differentiate the two NADH-Q reductases, 
yeast mitochondria were prepared from spheroplasts obtained 
by incubating yeast cells with zymolyase (16). Mitochondria 
prepared after zymolyase treatment showed low succinate- 
ferricyanide and succinate-DQ activities indicating that suc- 
cinate was not available to  the enzyme and  that  the mito- 
chondria were intact  (Table IV). In the same mitochondria, 
however, there was a very  high NADH-ferricyanide activity 
(950 nmol Fe3'/min/mg), which can be attributed to the 
enzyme on the outer surface of the membrane. The rate of 
DQ reduction by NADH in  the zymolyase-prepared, and  thus 
intact mitochondria, was approximately half that observed 
with broken mitochondria, and was not inhibited by myxo- 
196 Direct  Interactions of Complexes in Yeast Mitochondria 
thiazol (Table IV). In addition, no sensitivity to myxothiazol 
was observed when Qo, PQoCl, and menadione were used as 
electron acceptors. However, when the reduction of these  Q 
analogues was studied in submitochondrial particles, prepared 
from the same mitochondrial sample, sensitivity to myxothia- 
zol  was apparent  (Table IV). These  results indicate that  the 
NADH-Q reductase on the outer surface of the inner mem- 
brane  can directly reduce DQ and  the small analogues, but 
that  the NADH-Q reductase localized on the matrix surface 
of the membrane reduces them indirectly by electron transfer 
through the cytochrome b-cl complex. Since these  data sug- 
gest that center o is accessible to  the enzyme located at the 
inside of the membrane, the postulated location of center o 
toward the outside of the membrane may need to be reevalu- 
ated. 
Duroquinone Reduction by NADH in Beef Heart Mitochon- 
dria-Yeast lack site I of oxidative phosphorylation (23) 
suggesting that  the two NADH dehydrogenases are possibly 
smaller, less complicated enzymes than  their counterparts in 
mammalian mitochondria. Indeed, the NADH-Q reductase of 
yeast isolated by deVries (24) is composed of only one poly- 
TABLE IV 
Comparison of reactions and sensitivities  to myxothiazol in  different 
yeast  mitochondrial  preparations 
The methods of  preparation  of mitochondria and submitochondria 
particles are  described  under "Materials and Methods." The experi- 
mental conditions were the same as in Table 111. 
Mitochondrial preparation 
Glass Zymolyase Submito- 
beads digestion 
(broken) (intact) 
chondrial 
particles" 
Succinate-ferricyanideb 119 21 
Succinate-DQ' 14 0.9 
Sensitivity to myxothia- 
NADH-DQ' NDd 98 74 
NADH-DQ 
201 (%) 
43 0 36 
NADH-Qo 40 0 28 
NADH-MQ 54 0 34 
"Prepared from mitochondria isolated from yeast cells digested 
* Nanomole of Fe(CN)-3 reduced min"  mg". 
with zymolyase. 
Nanomole of DQ reduced min"  mg". 
ND, not determined. 
peptide. To see if the direct interaction with the  6-~1 complex 
is limited to small primary dehydrogenases such as succinate 
dehydrogenase and  the NADH-Q reductase in yeast, the re- 
duction of DQ by NADH was also studied in beef heart 
mitochondria. These mitochondria contain  a 12 subunit, 
transmembrane NADH-Q reductase with a site for energy 
coupling. Furthermore,  in beef heart mitochondria, the oxi- 
dation of NADH occurs strictly from the matrix side of the 
membrane. The mitochondria used in these studies were 
prepared by breaking beef heart muscle  cells with a blender 
(19) and hence are sufficiently damaged for NADH to reach 
its reaction site on the enzyme. It  can be seen from Fig. 2 
that the reduction of DQ by NADH was highly sensitive 
(74%) to  myxothiazol and somewhat sensitive (28%) to  anti- 
mycin. The results with inhibitors indicate that the large 
mammalian enzyme  complex also interacts directly with the 
cytochrome 6-cl complex. 
The Dependence of the Sensitivities to Antimycin and Myxo- 
thiazol on Temperature-The sensitivity of reduction of the 
small quinones by NADH and succinate to inhibitors of the 
6-cl complex suggests that  the pathway of electron transfer 
must involve the reaction sites of this complex,  where these 
inhibitors have been shown to interact. Furthermore, the 
dependence of the sensitivity on the substrate used, to  anti- 
mycin when succinate was the reductant  and to myxothiazol 
when NADH was used, suggests that  the reduction of the 
small quinone molecules may occur through a specific and 
direct interaction between the dehydrogenases and  the  6-~1 
complex. For example, the NADH dehydrogenase on the 
matrix side of the membrane may interact primarily with 
center 0, while succinate dehydrogenase may interact  primar- 
ily with center i of the b-cl complex via protein-protein 
interactions between the complexes. Such interactions would 
result from the movement of enzyme  complexes in  the mem- 
brane  and hence should be temperature dependent. 
Table V shows that lowering the temperature from 30 to 
14.5 "C greatly increased the antimycin inhibition of  DQ and 
Q, reduction by NADH in  the Q-deficient mutant; however, 
such an increased antimycin sensitivity was not observed in 
wild type mitochondria. By contrast, this temperature de- 
crease had only a small effect on the degree of myxothiazol 
inhibition of NADH reduction of these quinones in Q-defi- 
cient mitochondria, but essentially abolished the myxothiazol 
TABLE V
The  effect  of  temperature on the sensitivities of the  reduction of Qo and DQ to  antimycin  and myxothiazol 
The experimental conditions were the same as in Tables I1 and 111 for succinate and NADH as substrate, 
respectively. The reduction of DQ and QO was monitored at 270-247 nm. 
Sensitivity (%) 
Quinones 
Activity 
(nmol Q min" mg") 
Antimycin 
myxothiazol 
Temperature Antimycin Myxothiazol + 
M" W M W M W M W 
"C 
NADH as substrate 
Qo 14.5  204 100 47  7  69 0 79 46 
30.5 254 127 3  2 64 32  74 64 
DQ 14.5 154 128 63  -3 92 1 93 30 
30.5  240 168 20 8  79  43  85  63 
Succinate as substrate 
Qo 14.5 2.6 84  -4 
DQ 14.5 3.6 66 -3 
100 
30.5  8.4  55  -9  77 
100 
30.5  7.0 46 0 91 
a M and W refer to mutant (Q-deficient) and wild type mitochondria. 
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sensitivity in wild type mitochondria. A surprising observa- 
tion was that  the large temperature decrease (15.5 “C) had 
only a slight effect (20-30% decrease) on the  rate of electron 
transfer from NADH to DQ and Qo (Table V). 
For the studies with succinate as  the reductant, only the 
wild type mitochondria were used as the Q-deficient mito- 
chondria cannot catalyze the reduction of  DQ and Qo (Table 
11). The drop in temperature significantly increased the 
amount of antimycin inhibition,  and the reaction was com- 
pletely inhibited by the combined use of antimycin and myxo- 
thiazol. Moreover, the rate of reduction of DQ and Qo by 
succinate was  lowered  2-3-fold by the temperature change. 
DISCUSSION 
The results of the present  study suggest that protein-pro- 
tein interactions between the primary dehydrogenases and 
the cytochrome b-cl complex are involved in  the reduction of 
exogenous quinones. Furthermore, the myxothiazol sensitiv- 
ity of quinone reduction by NADH suggests that NADH-Q 
oxidoreductase preferentially interacts with center 0, while 
the antimycin sensitivity of the reduction by succinate sug- 
gests that succinate-Q oxidoreductase interacts preferentially 
with center i. 
Theoretically, exogenous quinones could be reduced by the 
mitochondrial respiratory  chain by any of the following pos- 
sible mechanisms: 1) direct electron transfer from the ubiqui- 
none reducing site on the primary dehydrogenases; 2) from 
endogenous Q6H2 formed by the primary dehydrogenases; 3) 
on center i and/or  center o of the cytochrome b-cl complex 
with free Q6HZ as the electron donor; 4) on  center i and/or 
center o of the cytochrome b-c, complex but with the electrons 
donated directly by the primary dehydrogenases through  pro- 
tein-protein  interactions between these complexes. 
The first mechanism represents the “classical” pathway of 
electron transfer  and does occur as evidenced by the antimy- 
cin- and myxothiazol-insensitive rate of quinone reduction; 
however, this mechanism cannot explain the observation that 
quinone reduction is largely blocked  by specific inhibitors of 
the cytochrome b-cl complex. The second mechanism requires 
direct quinol-quinone electron exchange without the involve- 
ment of protein which Rich (25) has shown to occur too slowly 
to explain the observed rates. Quinol-quinone reactions would 
also be insensitive to antimycin and myxothiazol. The  third 
mechanism involving the reduction of exogenous quinones 
with free QBH2 may occur to some extent; however, this 
mechanism fails to explain why quinone reduction is largely 
antimycin sensitive with succinate as electron donor and 
mainly myxothiazol sensitive with NADH as electron donor. 
It may  be argued that  the QsH2 formed by NADH-Q oxido- 
reductase goes preferentially to center o and  that formed by 
succinate-Q oxidoreductase to center i, but  such  a pathway is 
not consistent with the homogenous reduction kinetics of the 
Q pool observed in  the presence of a single substrate. 
The  fourth mechanism involving specific interactions be- 
tween the primary dehydrogenases and  the cytochrome b-e, 
complex not only explains the substrate-dependent sensitivi- 
ties to inhibitors of the b-c, complex, but also gives a possible 
explanation to  the large differences in  the rates of reduction 
of the small quinones with NADH and succinate as electron 
donors. The quinone-reducing site on NADH-Q oxidoreduc- 
tase, possibly due to  the more negative midpoint potential of 
NADH compared to succinate, may have a much greater 
reducing capacity to  the quinones on  the Q-reacting sites of 
the cytochrome b-cl complex. 
Protein-protein  interactions are also necessary to explain 
the reduction of small quinones in  the Q-deficient mitochon- 
dria that lack endogenous Q6. For example, the reduction of 
DQ  by DQH2 formed by the primary dehydrogenases will not 
create more  DQH,  molecules. Consequently, the reduction of 
DQ  which is antimycin-  and myxothiazol-sensitive must in- 
volve the transfer of electrons from the dehydrogenases di- 
rectly to DQ on the cytochrome b-e, complex. Similar reason- 
ing can explain the reduction of dichlorophenylindophenol by 
NADH in  the mitochondria lacking ubiquinone. 
In general, the sensitivity of  Q2 and DB reduction to anti- 
mycin and myxothiazol was low or not detectable suggesting 
that these quinones can interact directly with the primary 
dehydrogenases as do the endogenous quinones. The high 
concentrations of these analogues used in these experiments 
would also favor a direct interaction.  Protein-protein  inter- 
actions, however,  may well play a role in their reduction as 
evidenced by the 20-30% inhibition by myxothiazol in both 
wild type and Q-deficient mitochondria when  NADH  was the 
substrate. As discussed previously (9), direct protein-protein 
interactions  in electron transfer to quinones becomes impor- 
tant only when most of the quinone molecules are bound. 
Protein-protein  interactions may  occur through diffusion- 
based collisons, as  the diffusion rate of the various complexes 
in  the mitochondrial membrane has been calculated to occur 
more rapidly than electron transfer (2, 3). Alternatively, the 
complexes may occur in aggregated form (7, 8). Our data 
cannot distinguish between these two  models. 
The preferential interaction of center i and o with succinate 
and NADH oxidoreductases, respectively, suggests that these 
centers must each have different chemical properties as well 
as physical identities composed of different amino acid resi- 
dues on the same or different subunits of the complex. More- 
over, each center must be located at different sites on the 
cytochrome b-c, complex. The specific interactions proposed 
in the current study may offer an important clue as  to  the 
actual location of the two centers, especially center 0, in the 
inner membrane. The localization of succinate dehydrogenase 
at  the matrix side of the inner mitochondrial membrane in 
both mammalian and yeast mitochondria is consistent with 
the localization of center i at this side of the membrane where 
succinate-Q oxidoreductase and  the cytochrome b-cl complex 
might interact. 
By contrast, the generally accepted localization of center o 
(0 referring to  outer) on the outer side of the inner membrane 
in close proximity to  the iron-sulfur protein and cytochrome 
el (26) is inconsistent with the  interaction of this  center with 
NADH-Q oxidoreductase. The substrate oxidizing site of 
mammalian NADH-Q oxidoreductase has been shown to face 
the matrix, while the results of the current  paper  demonstrate 
that the yeast NADH dehydrogenase facing the matrix is 
involved in  the myxothiazol-sensitive (center 0) reduction of 
small quinones. These  results strongly suggest that center o 
may indeed be located far from the outer surface of the 
membrane, possibly near the center of the membrane. Placing 
center o at the center of the membrane is consistent with 
physical studies which have indicated that ubiquinone mole- 
cules are located at  the central region of the phospholipid 
bilayer (27). 
Furthermore, NADH-Q oxidoreductase can also interact 
with center i as indicated by the  partial sensitivity to  anti- 
mycin of the NADH reduction of the small quinones. The 
interaction of NADH-Q oxidoreductase with both centers o 
and i suggests that the two centers may be localized at a 
similar depth in the membrane especially if the movement of 
enzyme complexes occurs mainly in the plane of the mem- 
brane without much movement perpendicular to  the mem- 
brane. Such a localization is also consistent with the semi- 
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quinone model for electron transport in the cytochrome b-cl 
complex which proposes a ubiquinone pocket localized be- 
tween centers o and i (28). The suggestion that center o might 
be far from the outer surface of the membrane is also sup- 
ported by previous results from our laboratory suggesting that 
subunit VII, the Q-binding protein, is involved in electron 
transport at center o but faces the matrix side of the mem- 
brane (29). 
The effects of lowering the temperature on the rates of 
quinone reduction and on the degree of inhibition by the 
specific antibiotics suggest that endogenous quinone affects 
the interactions between the dehydrogenases and  the cyto- 
chrome b-cl complex. NADH-Q appears to interact more 
tightly with the b-cl complex, especially with center i in Q- 
deficient compared to wild type mitochondria as evidenced by 
the increased antimycin sensitivity at  the lower temperature. 
In the wild type mitochondria, the endogenous ubiquinone 
may hinder the interaction of NADH-Q reductase with center 
i as evidenced by the low antimycin sensitivity at either 
temperature  and the decreased sensitivity to myxothiazol at 
the lower temperature. Succinate-Q oxidoreductase in  the wild 
type mitochondria appears to  interact more tightly with the 
cytochrome b-cl complex at lower temperatures  as indicated 
by the increased sensitivity to antimycin and  the 100% inhi- 
bition by antimycin plus myxothiazol at 14.5 "C. Hence, low- 
ering the temperature may result in changes in  the distance 
between the complexes or in the depth of their Q-reacting 
sites in the membrane. 
Another important conclusion from this work is that each 
of the primary dehydrogenases have different structural re- 
quirements for their  interactions with the different quinones 
and quinone analogues. Previously, we reported that  the re- 
duction of  DQ  by succinate requires endogenous ubiquinone 
or ubiquinone homologues with an alkyl side chain  containing 
a minimum of two isoprene units.3 The  data of the  current 
paper  extend  this observation and suggest that all quinones 
with a plastoquinone-type ring as well as ubiquinones with a 
side chain  not more than 5 carbons long require endogenous 
quinone for their reduction by succinate dehydrogenase. In 
addition, the reduction of these analogues by succinate is 
highly sensitive to inhibitors of the cytochrome b-cl complex 
suggesting that even in the presence of endogenous quinone, 
these quinones do not react directly with succinate-ubiqui- 
none oxidoreductase. It is still  not clear which of the  three Q- 
reacting sites,  center 0, center i, or that on succinate dehydro- 
genase requires endogenous ubiquinone. 
NADH-Q oxidoreductase, on the other hand, appears to 
tolerate considerable changes in  the side chain and ring  struc- 
ture of the quinones. The antimycin-  and myxothiazol-insen- 
sitive rates of quinone reduction are high (as is the total 
reduction rate) indicating that  this enzyme can directly reduce 
all of the quinones tested with the exception of vitamin K1. 
Endogenous Q6 is not required for the direct reduction of 
these quinones. Indeed, its presence is actually inhibitory 
indicating that  the quinone reductions occur through the Q- 
reacting site on NADH dehydrogenase without the mediation 
of Qo. 
The results  obtained with Q1 were unexpected. The  rate of 
Ql reduction by either succinate or NADH was greater than 
that of Qo or DQ and similar to  that of  Qz or DB suggesting 
that Q1 may interact with the primary dehydrogenases in a 
similar manner  as  these analogues.  However, the reduction of 
Q1 by succinate required the presence of endogenous quinone 
and was inhibited 95% by antimycin while its reduction by 
NADH  was inhibited 82% by myxothiazol suggesting that Q1 
interacts with the respiratory chain in the same manner as 
Qo or DQ.  We thus conclude that Q1 is a poor choice to use 
for a replacement of  Q6 when studying reaction mechanisms 
of ubiquinone in the electron transfer  chain of yeast mito- 
chondria. 
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Direct  Interactions of Complexes in  Yeast Mitochondria 
Supplementary  material LO: Direct I n ~ e ~ a o C i O n  Between Yeast NADH-Ubiquinone 
Oxidoreductase in the  Reduction of Exogenous Quinones. Pin-shi Ehu and Diana S. Beattie. 
OXldoieduCtaPe,  SY00inate-UbiqYinODe  Oxidoreduotase and Ubiquinol-Cytochrome c 
Hateriais and Hethods 
(141, were obtained from Dr. Alexander Tzagoloff. The  cells  were g ~ o m  areoblcally at 30' 
The protorrophic strain, 0273-108 and the ubiquinone (Q)-defieient straln. E3-24 
In semisynthetic  medium ( 1 5 )  containing 31 galactose PI carbon ~ D U ? C ~  and harvested at the 
breaking cell9 with glass bead9 In the Wnomill  (Ehu and Bealtlea). In the Ofher method 
late  iogarlthmlc p h a ~ e  of  gPouth. Mitochondria sere obtained by two methods: one involves 
mitochondria were pFepaPed from SpheroplaSts  obtained by treating  the  cells  with  symolYaJe 
as describsd by Gasse3 (161. The mitochondria prepared by the latter method were WPe 
intact and thus used for Lhe determination of the sidene33 of the dehydrogenases. 
Submitochondrial  particles were prepared I n  0.1 M potasalum  phosphate buffs?. pH 7.5, Con- 
E3-24 Yere ahom t o  have no detectable  ubiquinone In Spectra o f  ether-methanol C X f r P C t J  
talning 0.1 mU EDTA according  to  Clejan  st al. (17). Mitochondria  obtained from atrain 
( 1  8). Beef heart  mitochondria YePe prepared  according t o  Crane et a l .  (19). 
buffer. pH 7.4. containlng 250 mM S Y C P O S ~  and 1 mH EDTA  using an Aminco-DW2C double  bean 
Unless otherwise stated, ell enzymatic reactions were performed in 50 LPM Trls-HC1 
dual wavelength rpeclrophotometer LherMSCated at  25OC. The wavelength pairs used for 
monitoring qulnone reductionil by different SubSLPLteJ rill be Peported in the Rtt(lult3 
section. 
(Vitamin K I I  were purchased from Sigma and myxoChiazoI from Boshringer  Haanhelo. 91 and 
Antlmyycln, CQ, menadione (vitamin K3) and 2-oethyl-3-phytyl-l14-naphrha9uinone 
Q2 (ubiquinone -1-21 Were a genePous g i f t  from Hoffman LaRoche. DB was prepared  according 
to Ua(argoll3 ( 2 0 ) .  90, PQOcl, PQocl0 and PO2 (methyl and decyl analogue Of PlartWuinOne) 
were synthesized In the  laboratory of Dr. L.Q.  Cu as previously  reported (6). All  these 
chamlcalz "ere addsd to the reaction mixture as ethanol solutlon~ when mitochondria 
preparatlona lacked ethanol dehydrogenase aCtiviLy. Uitochondria prcpaied from 
p'epared with the Wnoni l l  or rubmitachandrial particles YFPe med. Both of these 
rpheroplarts by the rymolyale method p095e9sed high ethanol dehydrogenase activity. 
Therefom, the  0xOgenou11  analogues w e ~ e  added ail dimethyl  aulfoxide solutiona. Fumarate 
was purchased from Brillsh Drug House. A11  other  chemicals were of the highe~t purity 
."allable. 
/ 
- reduced form 
------ oxidized fwm 
redox difference spectrum 
Table I 
Spectral  Analysis of Qulnonss 
ethanol and the  YBYelength  pairs used for  the  detection of thelr mductian by SYCCiIIBtO OP 
NADH. In all  the expari.snts 1.6 KCN wa3 Included  to pPavent aridation of the reduced 
quinones by the  respiratory chaln. 
TDe posltion of the negative peak o f  quinonea in their redox difference  Spectra In 
a, 268 
911 92 273-275  275-290 
268-290  70 47.  310-380
270-247, 340-380 
DB 279 279-290  5 1 ,  340-380
oa 266,  273 266-290  70 17,  340-380
Menadione 257,  264 264-290  70 47.  3 0-380
Vlt. K1 261,  269 269-290  70 47,  340-380
pQOcl* ppOelO~ pQ2 254-256 260-280  7 47,  310-380
Inhibition of dlehloroindophonol  (DCIPI  reduction In Yeast mltoehondria br antiwycln and 
myxothiasol. DCIP, an artirieial electron  acceptor of the  Pria8ry  flavoprotein 
dehydrogenaasa, is believed  to  Interact with the  mitochondrial  respiratory  chain  throush 
bound quinone, 1.8.. through the YbiqUinOne-reaCting EeDteP8. The reduction O f  DCIP bY 
%coinate in rlld  type  yeaat  mltochondrla war inhibited 742 by antimycin and 462 by my- 
xothiaeol  (Table VI). Furthermre, the  reduction of DCIP WBS almost  completely inhibitad 
in the  p~esencs  of both  antimycin and myxothisral  sugge3ting that the  YblquinOl bound to 
~uooinste dehydrogenase in the membrane cannot tranafer e1ect~OnS to DCIP YithoUt 
Involving both CenteP 1 and center 0 of the  cytochrome k-2, complsx. AI anticlpatad, 
mitochondria from the Q-deflclent yeast  could not reduce DCIP. 
nltochondria; hoYevar, the rate o f  reduction raa  almst double in the  mitochondria laioking 
In the presence of  NADH, OCIP 11I8 reduced by both rild type and Qdaflclsnt 
ubiquinone. In both wild-type and 9-deflolsnt  mitochondria,  the  Pate or K I P  mductlon 
vas innlbltsd Mderately by myxOthlaz01  and by antimycin. These result3 SUBBaat  that  NADH 
dehydrogenase can dlrectly  reduce OCIP in a rtlaction promoted by endogenouI 96 and that 
the  ubiquinol  produced by NADH  dehydrogenase 0%" 8130  transfer  electrons to KIP thmugh 
the antimycin and oyxothiarol  sensitive  site3 of the  ~ytoch~orne 1-2, CoOp1111. 
Table VI 
Inhibition Of DCIP Reduction By Antimycin And Myxothlazal 
HitoChOndrla ( 0  content 0.008 u M  and 0.016 Y M  for NADH redwtlon and Juceinlltc 
p~esence of 1.6 KCN. Then 2 mH Succinate OP 50 YM NADH was addsd  to  start tha 
Peductlon rerpsctlus~y) were incubated  with 50 u M  K I P  in Standard  buffer f o r  5 ain in the 
extinction coefficient of 0.9 mPT~3'was used to CalCulste activity. 
Peaotion. The Pddmtlon of DCIP nltored using the wavelength palr 600-630 nm. An 
Subatrate Activity Inhlhltion (L) 
In-1 DCIP mln-lmgll 
antimyycin myXomla.01 antimyycin 
plus  myrothlazol 
__ - - n u  - M Y  M Y  n u  
NADH 498  245  6 17 34 23 49  28 
succinate - 25.81 - 74 - 46 - 97 
